RecruitingNCT06430424

Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma

Study of Metabolic, Genomic and Proteomic Modifications in Relapsed Glioblastoma. Identification or Prognostic Markers in Patients Undergoing Surgery for Relapsed Glioblastoma.


Sponsor

University Hospital, Bordeaux

Enrollment

40 participants

Start Date

Apr 5, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Glioblastomas are the most frequent and aggressive malignant tumors of the CNS in adults, with almost systematic relapse despite treatment with surgery followed by radio-chemotherapy (STUPP protocol). The aim of this study is to better characterize transcriptomic, proteomic and metabolic changes in relapsed glioblastoma compared to the initial tumor, in order to identify new prognostic markers and potential new therapeutic targets.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is an observational research project analyzing tumor tissue samples — stored from past surgeries — from people who had surgery for glioblastoma (an aggressive brain tumor) both the first time and at recurrence. Researchers will look at genetic, protein, and metabolic characteristics of the tumors to understand why glioblastoma comes back and becomes resistant to treatment. **You may be eligible if...** - You are over 18 years old - You had surgery for primary (first-time) glioblastoma AND recurrent glioblastoma between 2005 and 2023 at the Bordeaux University Hospital (CHU de Bordeaux) **You may NOT be eligible if...** - You received systemic therapy (such as chemotherapy or targeted therapy) for a different, non-glioblastoma tumor Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALRelapsed glioblastoma

Paired tumor samples diagnosis/relapse


Locations(1)

CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médicale

Bordeaux, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06430424


Related Trials